XML 37 R25.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Jul. 31, 2020
Accounting Policies [Abstract]  
Schedule of revenue recognized
    Year Ended July 31,
Revenue Source   2020   2019
Product sales   $ 2,643,228     $ 105,432  
Management services     18,168       370,118  
Pharmacy sales     —         5,409,644  
Laboratory sales     —         318,567  
Total Revenue   $ 2,661,396     $ 6,203,761  
Schedule of intangible assets

Impairment of Long-lived assets for the year ending July 31, 2019

    Grainland Pharmacy   Empire State Pharmacy   Total
Intangible assets   $ 99,519     $ 188,068     $ 287,587  
Goodwill     —         —         —    
Total impairment of intangible assets   $ 99,519     $ 188,068     $ 287,587  

 

Impairment of Long-lived Assets for the year ending July 31, 2020

 

    Veneto   MediSource   Pantheon   Total
Tradenames   $ —       $ 47,600     $ 55,400     $ 103,000  
Intellectual Property     —         —         41,500       41,500  
Customer Base     —         346,800       274,600       621,400  
Non-Compete Agreements     —         124,600       232,100       356,700  
Less: Amortization     —         (67,827 )     (116,820 )     (184,647 )
Total impairment of intangible assets     —         451,173       486,780       937,953  
Impairment of goodwill     3,808,231       471,626       131,927       4,411,784  
Total impairment of intangible assets and goodwill   $ 3,808,231     $ 922,799     $ 618,707     $ 5,349,737  
Schedule of estimated useful lives

Property and equipment are depreciated using the straight-line method over the estimated useful lives of the assets, which are generally as follows:

Leasehold improvements The shorter of the expected useful life of the improvement or the lease term
Computers and technological assets 3-5 years
Machinery and equipment 3-5 years
Furniture and fixtures 3-7 years
Fair Value, Liabilities Measured on Recurring Basis

The following is a listing of the Company’s liabilities required to be measured at fair value on a recurring basis and where they are classified within the fair value hierarchy as of July 31, 2020 and July 31, 2019:

    July 31, 2020
    Level 1   Level 2   Level 3   Total
Derivative liability   $ —       $ —       $ 1,316,757     $ 1,316,757  
Total   $ —       $ —       $ 1,316,757     $ 1,316,757  

 

   

 

July 31, 2019

    Level 1   Level 2   Level 3   Total
Derivative liability   $ —       $ —       $ 7,820,282     $ 7,820,282  
Total   $ —       $ —       $ 7,820,282     $ 7,820,282